Mengqi Hu

Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development

R. Molden, Mengqi Hu, Sook Yen E, 2021, mAbs.

Discovery of talmapimod analogues as polypharmacological anti-inflammatory agents

Xiaodong Ma, Mengqi Hu, Caiyun Hou, 2019, Journal of enzyme inhibition and medicinal chemistry.

Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes

Xiaodong Ma, Mengqi Hu, Jiaming Li, 2018, Chemical biology & drug design.

Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.

Xiaodong Ma, Qihua Zhu, Mengqi Hu, 2021, European journal of medicinal chemistry.

Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.

Xiaodong Ma, Mengqi Hu, Jiaming Li, 2018, European journal of medicinal chemistry.

Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling

Xiaodong Ma, Mengqi Hu, Jiaming Li, 2019, Anti-cancer drugs.

Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.

R. Molden, Mengqi Hu, Haibo Qiu, 2021, Journal of pharmaceutical and biomedical analysis.